暴露性角膜炎的治疗进展

doi:10.3760/cma.j.issn.1007-1245.2022.12.002

摘要/Abstract

摘要： 暴露性角膜炎是指角膜暴露于外周环境中，失去了眼睑的保护，引起角膜上皮脱落，水分丢失，从而发生角膜感染。是一种可致盲致残的疾病，所以，对此病的治疗及预防具有较为重要的现实意义。本文就此病的临床治疗现状、方法、进展作一综述。

Abstract: Exposure keratitis is to show that the cornea is exposed to the peripheral environment, loses the protection from eyelid, and causes corneal epithelial detachment and loss of moisture, resulting in corneal infection. It is a kind of disease that can cause blindness and disability, so the treatment and prevention of this disease has important practical significance. This article reviews the clinical treatment status, methods, and progress of this disease.

Key words: Exposed keratitis, Infection, Treatment status, Research progress

许行艳, 周友弟. 暴露性角膜炎的治疗进展[J]. 国际医药卫生导报, 2022, 28(12): 1633-1635.

Xu Xingyan, Zhou Youdi. Treatment progress of exposed keratitis[J]. International Medicine and Health Guidance News, 2022, 28(12): 1633-1635.

参考文献

[1] 王建荣,丁淑贞,冯红. ICU患者暴露性角膜炎影响因素及干预对策进展[J]. 中国护理管理,2018,18(6):861-864. DOI:10.3969/j.issn.1672-1756.2018.06.031.

[2] Baugh RF, Basura GJ, Ishii LE, et al. Clinical practice guideline: Bell's Palsy executive summary[J].Otolaryngol Head Neck Surg,2013,149(5):656-663. DOI:10.1177/0194599813506835.

[3] 刘木,高莹莹. 周围性面瘫所致眼部损害的治疗进展[J]. 中国实用眼科杂志,2015,33(2):115-118. DOI:10.3760/cma.j.issn.1006-4443.2015.02.006.

[4] Wolkow N, Chodosh J, Freitag SK. Innovations in treatment of lagophthalmos and exposure keratopathy[J].Int Ophthalmol Clin,2017,57(4):85-103. DOI:10.1097/IIO.0000000000000185.

[5] Biglioli F. Facial reanimations: part II--long-standing paralyses[J].Br J Oral Maxillofac Surg,2015,53(10):907-912. DOI:10.1016/j.bjoms.2015.07.001.

[6] Yip CC, Gonzalez-Candial M, Jain A, et al. Lagophthalmos in enophthalmic eyes[J].Br J Ophthalmol,2005,89(6):676-678. DOI:10.1136/bjo.2004.052845.

[7] 王旭,高芯,张玉光. 角膜胶原交联术治疗有严重感染的暴露性角膜炎[J]. 中华眼外伤职业眼病杂志,2020,42(7):536-540. DOI:10.3760/cma.j.cn116022-20191228- 00452.

[8] Mancini R, Taban M, Lowinger A, et al. Use of hyaluronic Acid gel in the management of paralytic lagophthalmos: the hyaluronic Acid gel "gold weight"[J].Ophthalmic Plast Reconstr Surg,2009,25(1):23-26. DOI:10.1097/IOP.0b013e318192568d.

[9] Tuna SH, Gumus HO, Hersek N. Custom-made gold implant for management of lagophthalmos: a case report[J].Eur J Dent,2008,2(4):294-298.

[10] Bianchi B, Ferri A, Leporati M, et al. Upper eyelid platinum chain placement for treating paralytic lagophthalmos[J].J Craniomaxillofac Surg,2014,42(8):2045-2048. DOI:10.1016/j.jcms.2014.09.012.

[11] Jones L, Downie LE, Korb D, et al. TFOS DEWS II management and therapy report[J].Ocul Surf,2017,15(3):575-628. DOI:10.1016/j.jtos.2017.05.006.

[12] 刘月,王玉巧,杨如萍,等. 八宝眼膏对暴露性角膜炎大鼠治疗作用的研究[J]. 中国中医眼科杂志,2021,31(8):544-547. DOI:10.13444/j.cnki.zgzyykzz.2021.08.003.

[13] 刘宇,崔珊珊. 维生素C局部应用治疗角膜炎和角膜溃疡的效果分析[J]. 中国现代药物应用,2020,14(6):166-168. DOI:10.14164/j.cnki.cn11-5581/r.2020.06.079.

[14] Ezra DG, Lewis G, Healy M, et al. Preventing exposure keratopathy in the critically ill: a prospective study comparing eye care regimes[J].Br J Ophthalmol,2005,89(8):1068-1069. DOI:10.1136/bjo.2004.062406.

[15] 黄锋. 普拉洛芬滴眼液联合小牛血去蛋白提取物眼用凝胶治疗中重度干眼症的药学效果分析[J]. 北方药学,2020,17(12):143-144.

[16] 唐敏,岳丽菁,张阳,等. 小牛血去蛋白提取物眼用凝胶治疗暴露性角膜炎的临床疗效研究[J]. 按摩与康复医学,2021,12(24):57-59. DOI:10.19787/j.issn.1008-1879.2021. 24.018.

[17] Leung VC, Belovay GW, Chan CC. TegadermTMdressing and Lacri-lube ointment moisture chamber to manage exposure keratopathy[J].Can J Ophthalmol,2016,51(5):e149-e151. DOI:10.1016/j.jcjo.2016.05.010.

[18] Custer PL. Ophthalmic management of the facial palsy patient[J].Semin Plast Surg,2004,18(1):31-38. DOI:10.1055/s-2004-823121.

[19] 马贵荣,黄丽仙,韦柳霞. 循证眼部护理对神经外科昏迷患者暴露性角膜炎的影响[J]. 护理实践与研究,2021,18(12):1858-1860. DOI:10.3969/j.issn.1672-9676.2021.12.034.

[20] 厉春林,周雁荣,王兰,等. 重症患者暴露性角膜炎预防及管理最佳证据总结[J]. 护理学杂志,2021,36(20):100-103. DOI:10.3870/j.issn.1001-4152.2021.20.100.

[21] 苏暄. 享受"无镜"美好生活老视及多焦人工晶状体全球最新应用进展和趋向[J]. 中国医药科学,2017,7(12):3-6.

[22] 黄月华,庄水冰,蔡敏,等. 医护品管圈在降低危重症患者暴露性角膜炎的发生率中的应用[J]. 岭南现代临床外科,2019,19(4):499-502,506. DOI:10.3969/j.issn.1009- 976X.2019.04.029.

[23] Hao Y, Ma DH, Hwang DG, et al. Identification of antiangiogenic and antiinflammatory proteins in human amniotic membrane[J].Cornea,2000,19(3):348-352. DOI:10.1097/00003226-200005000-00018.

[24] 柯兰,杨燕宁. 羊膜移植治疗暴露性角膜炎的临床疗效观察[J]. 国际眼科杂志,2017,17(4):743-745. DOI:10.3980/j.issn.1672-5123.2017.4.40.

[25] Prabhasawat P, Tesavibul N, Komolsuradej W. Single and multilayer amniotic membrane transplantation for persistent corneal epithelial defect with and without stromal thinning and perforation[J].Br J Ophthalmol,2001,85(12):1455-1463. DOI:10.1136/bjo.85.12.1455.

[26] Hick S, Demers PE, Brunette I, et al. Amniotic membrane transplantation and fibrin glue in the management of corneal ulcers and perforations: a review of 33 cases[J].Cornea,2005,24(4):369-377. DOI:10.1097/01.ico.0000151547.08113.d1.

[27] 谭越,王旭,髙芯,等. 深板层角膜移植术治疗感染性角膜炎的效果[J]. 中华眼外伤职业眼病杂志,2021,43(6):405-410. DOI:10.3760/cma.j.cn116022-20201215-00479.

[28] 杜燕,杨玉芹,牛璐. 泳镜在听神经鞘瘤术后眼睑闭合不全患者护理中的应用[J]. 上海护理,2021,21(3):51-53. DOI:10.3969/j.issn.1009-8399.2021.03.013.

[29] Weyns M, Koppen C, Tassignon MJ. Scleral contact lenses as an alternative to tarsorrhaphy for the long-term management of combined exposure and neurotrophic keratopathy[J].Cornea,2013,32(3):359-361. DOI:10.1097/ICO.0b013e31825fed01.

[30] Gire A, Kwok A, Marx DP. PROSE treatment for lagophthalmos and exposure keratopathy[J].Ophthalmic Plast Reconstr Surg,2013,29(2):e38-e40. DOI:10.1097/IOP.0b013e3182674069.

[31] 伍丹丹. 穴位埋线治疗面瘫后暴露性角膜炎1例[J/CD]. 全科口腔医学杂志(电子版),2020,7(6):116. DOI:10.16269/j.cnki.cn11-9337/r.2020.06.087.

[32] Choi JA, Chung SH. Combined application of autologous serum eye drops and silicone hydrogel lenses for the treatment of persistent epithelial defects[J].Eye Contact Lens,2011,37(6):370-373. DOI:10.1097/ICL.0b013e318233c9bb.

[33] Moon CH, Kim JY, Kim MJ, et al. Effect of three-dimensional printed personalized moisture chamber spectacles on the periocular humidity[J].J Ophthalmol,2016,2016:5039181. DOI:10.1155/2016/5039181.